
Erin Boh
Articles
-
Sep 7, 2023 |
dermatologytimes.com | Mark Lebwohl |Erin Boh
Mark Lebwohl, MD: The patient I’m presenting is a 58-year-old woman who was in good health. She did not know she had a diagnosis of psoriasis. She developed joint pains and saw a rheumatologist who diagnosed her with presumed rheumatoid arthritis and treated her with hydroxychloroquine. Two weeks later, she developed a generalized eruption characterized by erythema and covered with pustules, with many of the pustules becoming confluent to form lakes of puss.
-
Aug 31, 2023 |
dermatologytimes.com | Mark Lebwohl |Erin Boh
August 31, 2023Experts in dermatology hypothesize about the management of patients with chronic vs acute GPP episodes. Erin Boh, MD: I will say it is a very easy drug to use and you don’t use it all the time. You might have patients who are on it more. When I say regularly, not like you would do it regularly.
-
Aug 31, 2023 |
dermatologytimes.com | Mark Lebwohl |Erin Boh
Erin Boh, MD: It is important to find the trigger because when it’s steroids, sometimes putting the patient back on that trigger—which sounds rather paradoxical—might be the best thing to do. Then slowly taper them down and off as you get them on the drug of choice, which is this now FDA-approved therapy for pustular psoriasis. I do think that rapid withdrawal is just hard to manage. Mark Lebwohl, MD: Now that you’ve told this story, I’m going to use it. I don’t know what the percentage of death is.
-
Aug 24, 2023 |
dermatologytimes.com | Mark Lebwohl |Erin Boh
Aug 24, 2023Experts in dermatology provide insight into the importance of multidisciplinary care in the management of patients with generalized pustular psoriasis (GPP). Erin Boh, MD: I will say that after her first, dose administration, which is easy to do, there’s no real prepping or anything like that. You don’t need to premedicate, you don’t need to have long infusion times. Literally, the infusion of the drug is over in about 90 minutes. So, it’s, wham bam, done. Thank you.
-
Aug 24, 2023 |
dermatologytimes.com | Mark Lebwohl |Erin Boh
Aug 24, 2023Erin Boh, MD, shares her opinion on the importance of proactively stocking and streamlining generalized pustular psoriasis (GPP) medication pathways due to emergent care requirements of GPP. Erin Boh, MD: I think that as we get more familiar with the drug, it’s going to hopefully be that way because there are people who do have chronic flares. And my patient, and I’m not sure about yours, and I’d love to hear about it.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →